Adverse effects of anti-epileptic, anti-hypertensive, anti-diabetic and anti-arrhythmic drugs on hematological and hepatic parameters by Afroz, Syeda et al.
229ISSN 0326-2383
KEY WORDS: Cumulative adverse effects, Hematological and hepatic parameters. 
* Author to whom correspondence should be addressed. E-mail: rkhan1959@gmail.com
Latin American Journal of Pharmacy
(formerly Acta Farmacéutica Bonaerense)
Lat. Am. J. Pharm. 30 (2): 229-36 (2011)
Original Article
Received: March 26, 2010
Revised version: June 10, 2010
Accepted: June 13, 2010
Adverse Effects of Anti-Epileptic, Anti-Hypertensive, Anti-Diabetic
and Anti-Arrhythmic Drugs on Hematological and Hepatic Parameters
Zeeshan FEROZ, Rafeeq A. KHAN* & Syeda AFROZ
Department of Pharmacology, University of Karachi, Karachi-75270, Pakistan
SUMMARY. Multiple drug administration increases chances of drug interaction, altering the responses of
drugs either increasing or decreasing pharmacological effects, or generating a new pharmacological re-
sponse. Generally drug interactions should be avoided, due to the possibility of poor or unexpected out-
comes. The present study was designed to explore relatively safe combination that can be used in individu-
als with multiple disorders such as epilepsy, hypertension, arrhythmia and diabetes. The study was con-
ducted in normal rabbits of either sex following administration of drugs for a period of 60 days; various
biochemical tests were performed to assess their hepatic and hematological profile. Results of this study
suggest that animals of group receiving amiodarone-glibenclamide-captopril-oxcarbazepine combination
revealed comparatively more toxic effects than two other combinations.
